9.15
-0.24(-2.56%)
Currency In USD
| Previous Close | 9.39 |
| Open | 9.45 |
| Day High | 9.45 |
| Day Low | 9.14 |
| 52-Week High | 15.69 |
| 52-Week Low | 8.03 |
| Volume | 1.3M |
| Average Volume | 2.23M |
| Market Cap | 1.47B |
| PE | 130.71 |
| EPS | 0.07 |
| Moving Average 50 Days | 9.22 |
| Moving Average 200 Days | 10.94 |
| Change | -0.24 |
If you invested $1000 in Certara, Inc. (CERT) since IPO date, it would be worth $240.28 as of January 14, 2026 at a share price of $9.15. Whereas If you bought $1000 worth of Certara, Inc. (CERT) shares 5 years ago, it would be worth $266.53 as of January 14, 2026 at a share price of $9.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Certara Appoints Jon Resnick as Chief Executive Officer
GlobeNewswire Inc.
Dec 11, 2025 11:00 AM GMT
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year 2025 financial outlook RADNOR, Pa
Certara Automates Scientific Workflows with Phoenix® Cloud
GlobeNewswire Inc.
Nov 04, 2025 1:00 PM GMT
New cloud capabilities cut time to create Tables, Figures, and Listings by 50%RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio,
Certara Expands Biosimulation Market with AI-Driven QSP Platform
GlobeNewswire Inc.
Oct 30, 2025 8:15 PM GMT
Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapiesRADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-in